Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Horn L, Spigel DR, Vokes EE, Holgado E, et al. Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). J Clin Oncol 2017 Oct 12:JCO2017743062. doi: 10.1200/JCO.2017.74.3062.
PMID: 29023213


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016